These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8727310)

  • 1. Interferons in melanoma.
    Agarwala SS; Kirkwood JM
    Curr Opin Oncol; 1996 Mar; 8(2):167-74. PubMed ID: 8727310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of interferons in the therapy of melanoma.
    Kirkwood JM; Ernstoff MS
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):180S-184S. PubMed ID: 1701805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated interferons: prospects for the use in the adjuvant and palliative therapy of metastatic melanoma.
    Kaehler KC; Sondak VK; Schadendorf D; Hauschild A
    Eur J Cancer; 2010 Jan; 46(1):41-6. PubMed ID: 19857957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on adjuvant interferon therapy for high-risk melanoma.
    Agarwala SS; Kirkwood JM
    Oncology (Williston Park); 2002 Sep; 16(9):1177-87; discussion 1190-2, 1197. PubMed ID: 12380946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of interferon in melanoma patients: a systematic review.
    Di Trolio R; Simeone E; Di Lorenzo G; Buonerba C; Ascierto PA
    Cytokine Growth Factor Rev; 2015 Apr; 26(2):203-12. PubMed ID: 25511547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of interferons in malignant melanoma.
    McLeod GR; Thomson DB; Hersey P
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):185S-187S. PubMed ID: 1701806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy in melanoma.
    Mohr P; Weichenthal M; Hauschild A
    Onkologie; 2003 Jun; 26(3):227-33. PubMed ID: 12845206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of interferons in the therapy of melanoma.
    Kirkwood JM
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):83-90. PubMed ID: 1948134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant interferon treatment for melanoma.
    Agarwala SS; Kirkwood JM
    Hematol Oncol Clin North Am; 1998 Aug; 12(4):823-33. PubMed ID: 9759581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic adjuvant treatment of high-risk melanoma: the role of interferon alfa-2b and other immunotherapies.
    Kirkwood JM
    Eur J Cancer; 1998 Jul; 34 Suppl 3():S12-7. PubMed ID: 9849403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical appraisal of IFN-alpha-based adjuvant therapy in stage II-III malignant melanoma.
    Eggermont AM
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):563-9. PubMed ID: 12382524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient management strategies for interferon alfa-2b as adjuvant therapy of high-risk melanoma.
    Donnelly S
    Oncol Nurs Forum; 1998 Jun; 25(5):921-7. PubMed ID: 9644709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma.
    Verma S; Quirt I; McCready D; Bak K; Charette M; Iscoe N
    Cancer; 2006 Apr; 106(7):1431-42. PubMed ID: 16511841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence.
    Kimyai-Asadi A; Usman A
    J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy for melanoma.
    Sondak VK
    Cancer J; 2001; 7 Suppl 1():S24-7. PubMed ID: 11504282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the role of adjuvant interferon for high risk melanoma.
    Agarwala SS; Kirkwood JM
    Forum (Genova); 2000; 10(3):230-9. PubMed ID: 11007931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role interferon-alpha in malignant melanoma remains to be defined.
    Eggermont AM
    Eur J Cancer; 2001 Nov; 37(17):2147-53. PubMed ID: 11677100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferons and malignant melanoma].
    Dreno B
    Rev Med Interne; 2002 Nov; 23 Suppl 4():489s-493s. PubMed ID: 12481404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy and chemoimmunotherapy in disseminated malignant melanoma.
    Garbe C
    Melanoma Res; 1993 Aug; 3(4):291-9. PubMed ID: 7693093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
    McMasters KM; Edwards MJ; Ross MI; Reintgen DS; Martin RC; Urist MM; Noyes RD; Sussman JJ; Stromberg AJ; Scoggins CR
    Ann Surg; 2010 Sep; 252(3):460-5; discussion 465-6. PubMed ID: 20739846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.